Result : 7

Metabolic dysfunction associated steatohepatitis, epidemiology and definitions: from steatosis to cirrhosis

A recent change in terminology proposed by scientific societies replaces the term NAFLD (non-alcoholic fatty liver disease) with the term MASLD (metabolic dysfunction associated steatotic liver...
 Raluca Pais. September 2026, page 14

Diagnostic approach for metabolic dysfunction associated steatotic liver disease

Metabolic dysfunction associated steatotic liver disease (MASLD) is a systemic disease affecting the liver. The diagnostic approach consists of the identification of hepatic steatosis, the...
 Lucia Parlati, Charlotte Mouliade, Stanislas Pol. September 2026, page 19

FIB-4: a simple blood test to identify patients at risk of liver complications

 Jérôme Boursier, Frédéric Oberti. September 2026, page 24

Current and future medical treatments for metabolic dysfunction-associated steatohepatitis

Drug treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) is undergoing a revolution. The fight against cardiovascular risk factors, the optimization of the treatment of...
 Rodolphe Anty, Marwin A Farrugia. September 2026, page 26

The role of bariatric surgery and endoscopy in the management of MASLD

The epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD), amplified by shifting dietary habits and increasing sedentary lifestyles, has elevated metabolic...
 Nawel Chouraqui, Guillaume Lassailly. September 2026, page 36

Steatosis and steatohepatitis: a risk factor for complications after liver resection

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), have become common clinical conditions in...
 Karim Boudjema, Fabien Robin, Heithem Jeddou, Pauline Houssel-Debry. September 2026, page 40

Metabolic dysfunction-associated steatotic liver diseases: 10 key messages

 Catherine Buffet. September 2026, page 45